-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeBankruptcy, Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia, Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
- 2025-09-04
-
Zhong Lun Advises Ad Hoc Committee of Noteholders on Successful Restructuring of Yuzhou Group’s USD 6.7bn Offshore Debt
Zhong Lun Law Firm served as PRC counsel to an ad hoc group of Yuzhou Group’s offshore noteholders.
-
- 2025-08-27
-
Zhong Lun Advises Sleemon on Acquisition of Certain Equity in Jiaxing Milano & Design
Zhong Lun represented Sleemon in the transaction.
-
- 2025-08-26
-
Zhong Lun Assists Yijun Capital and Huatai Jijin in Completing Series B1 Investment in Rino.ai
Zhong Lun Law Firm acted as legal advisor for Yijun Capital and Huatai Fund in this Transaction, providing services spanning legal due diligence investigation, drafting and revision of transaction documents, negotiation, as well as the closing.
-
- 2025-08-07
-
Zhong Lun Advises Everest Medicines on Top-up Placement
Zhong Lun Law Firm acted as the PRC advisor to Everest Medicines in this placement.